A small randomized trial tested 50 mg of quetiapine at bedtime in adults with obstructive sleep apnea and trouble staying asleep, and the drug improved several nighttime measures but left participants groggy and slower to react the next morning.
Fifteen people with obstructive sleep apnea who also had difficulty maintaining sleep spent two nights in the lab: one night on 50 mg of quetiapine and one on a placebo. Researchers tracked breathing, brain activity, oxygen levels and leg movements to get a clear read on sleep quality and respiratory events. Compared with placebo, the quetiapine night produced more total sleep time and substantially less wakefulness. Those gains came alongside a drop in apnea-related events, from about 27 per hour down to roughly 20 per hour in this small group.
Despite measurable sleep improvements, the mornings after quetiapine showed troubling signs for safety. Participants were slower on a 10-minute reaction time test and performed worse in a driving simulator, with more attention lapses and more lane departures. Eleven of the 15 reported feeling sleepier the morning after the drug night, and roughly one in four people did not recognize how impaired they were, which raises obvious concerns about driving or operating machinery.
Side effects were mostly mild to moderate but not trivial: nausea, restless legs and an abrupt drop in blood pressure when standing were all reported. That last effect occurred in about one-third of those on quetiapine, which could increase fall risk, particularly among older adults. The trial authors flagged the small sample size and the single-night, laboratory setting as limits that prevent sweeping conclusions. Still, the pattern is clear enough to call for caution.
Given the next-day effects, the researchers advised avoiding driving or other safety-sensitive tasks for at least 9.5 hours after taking quetiapine. That recommendation is practical: even if a medication helps you sleep longer, it can leave behind cognitive and motor sluggishness that matters the moment you get behind the wheel. In the study, objective tests showed slowed reaction time and more swerving despite the sleep gains, which is the opposite of what most people want from a sleep aid.
Experts also pointed out that men and women may process these drugs differently, which could change both benefit and risk profiles. “Future studies should carefully examine whether these newer agents demonstrate similar sex-specific patterns to ensure optimal dosing and safety recommendations,” was the exact call for more nuanced research. Understanding metabolism differences matters when the trade-off is better sleep versus impaired daytime alertness.
“This population is already vulnerable to cognitive and related side effects related to polypharmacy, making it essential to understand the potential trade-offs between sleep benefits and daytime functioning,” echoed another expert, highlighting why older adults deserve particular attention. Polypharmacy can magnify sedative effects and complicate how any single drug shows up in daily life. That makes longer trials across diverse groups essential before changing prescribing habits for sleep apnea or insomnia based on one-night lab results.
“Even when medications are effective in the short term, behavioral interventions such as cognitive behavioral therapy for insomnia remain an important component of long-term management,” the experts reminded clinicians and patients alike. Non-drug strategies can fix the learned behaviors and thoughts that sustain insomnia without adding next-day impairment. For many people with sleep apnea, combining device therapy, lifestyle changes and targeted behavioral care will still be the safest path.
“But if they’re taking quetiapine for sleep, especially if they have sleep apnea or wake up feeling groggy, they should talk with their doctor about whether the benefits outweigh the risks and whether other treatment options might be appropriate,” advised a sleep specialist, underlining the practical takeaway. Until larger, longer trials arrive, anyone considering quetiapine for sleep should weigh possible nighttime gains against measurable morning impairment and be cautious about safety-critical activities after dosing.
